In response to environments that cause cellular stress, animals engage in sleep behavior that facilitates recovery from the stress. In Caenorhabditis elegans, stress-induced sleep(SIS) is regulated by cytokine activation of the ALA neuron, which releases FLP-13 neuropeptides characterized by an amidated arginine-phenylalanine (RFamide) C-terminus motif. By performing an unbiased genetic screen for mutants that impair the somnogenic effects of FLP-13 neuropeptides, we identified the gene dmsr-1, which encodes a G-protein coupled receptor similar to an insect RFamide receptor. DMSR-1 is activated by FLP-13 peptides in cell culture, is required for SIS in vivo, is expressed non-synaptically in several wake-promoting neurons, and likely couples to a Gi/o heterotrimeric G-protein. Our data expand our understanding of how a single neuroendocrine cell coordinates an organism-wide behavioral response, and suggest that similar signaling principles may function in other organisms to regulate sleep during sickness.https://doi.org/10.7554/eLife.19837.001
People often feel fatigued and sleepy when they are sick. Other animals also show signs of sleepiness when ill – they stop eating, move less, and are less responsive to changes in their environment. Sickness-induced sleep helps both people and other animals to recover, and many scientists believe that this type of sleep is different than nightly sleep.
Studies of sickness-induced sleep have made use of a simple worm with a simple nervous system. In this worm, a single nerve cell releases chemicals that cause the worm to fall asleep in response to illness. Animals exposed to one of these chemicals, called FLP-13, fall asleep even when they are not sick. As such, scientists would like to know which cells in the nervous system FLP-13 interacts with, what receptor the cells use to recognize this chemical, and whether it turns on cells that induce sleep or turns off the cells that cause wakefulness.
Now, Iannacone et al. show that FLP-13 likely causes sleep by turning down activity in the cells in the nervous system that promote wakefulness. The experiments sifted through genetic mutations to determine which ones cause the worms not to fall asleep when FLP-13 is released. This revealed that worms with a mutation that causes them to lack a receptor protein called DMSR-1 do not become sleepy in response to FLP-13. This suggests that DMSR-1 must be essential for FLP-13 to trigger sleep. About 10% of cells in the worm’s nervous system have the DMSR-1 receptor. Some of these neurons tell the worm to move forward or to forage around for food. The experiments also showed that FLP-13 is probably not the only chemical that interacts with the DMSR-1 receptor, but the identities of these other chemicals remain unknown.
Additional experiments are now needed to determine if sickness-induced sleepiness in humans and other mammals is triggered by a similar mechanism. If it is, then drugs might be developed to treat people experiencing fatigue associated with sickness as well as other unexplained cases of fatigue.https://doi.org/10.7554/eLife.19837.002
When acutely ill, animals engage in a behavioral sequence that includes cessation of feeding and body movements as well as reduced responsiveness to the environment. During acute infectious illness in mammals, electrophysiological correlates of sleep behavior are observed (Toth and Krueger, 1988, 1989), indicating that the behavioral sequence is sleep. In the arthropod Drosophila melanogaster (Williams et al., 2007; Lenz et al., 2015) and the nematode Caenorhabditis elegans (Hill et al., 2014), acute illness results in cellular stress, which then induces a sleep behavior: the animals stop moving and feeding, do not respond to weak stimuli but move normally in response to strong stimuli (Hill et al., 2014). This stress-induced sleep (SIS, also known as sickness sleep) is beneficial to the animal and helps it recover from the acute injury (Spiegel et al., 2002; Hill et al., 2014; Kuo and Williams, 2014; Fry et al., 2016). In fruit flies and round worms, environments that induce SIS include bacterial pathogens, bacterial toxins, heat shock, cold shock, osmotic shock, and ultraviolet light exposure (Hill et al., 2014; Lenz et al., 2015). A comparison between mammalian sickness sleep and invertebrate SIS was recently reviewed (Davis and Raizen, 2016).
Nematode SIS is a distinct sleep state from a larval sleep state known as developmentally timed sleep (DTS) (Trojanowski et al., 2015), which is regulated by a homolog of the core circadian protein PERIOD (Monsalve et al., 2011). In the absence of stress, nematodes experience sleep only when they transition between larval stages but do not sleep in the adult stage. Since C. elegans does not have an identifiable circadian rhythm of sleep, adult nematodes are an ideal system to study SIS in the absence of the circadian and homeostatic effects of animals that require daily sleep.
The mechanism of SIS is poorly-understood, yet a few common themes have emerged from studies across phylogeny. The acute illness can occur outside of the brain yet affect behavior, suggesting that communication occurs between non-neural and neural tissues. Cytokine signaling is involved. For example, in mammals, the cytokines interleukin-1 beta and tumor necrosis factor alpha, whose levels increase during an infectious challenge, are each sufficient to induce sleep when injected into the brain (reviewed in (Krueger, 2008). In nematodes (Van Buskirk and Sternberg, 2007), arthropods (Foltenyi et al., 2007), and mammals (Kushikata et al., 1998; Kramer et al., 2001), signaling by epidermal growth factor (EGF) is sufficient to induce sleep behavior and, at least in nematodes, EGF signaling is necessary for SIS (Hill et al., 2014). These cytokines act on central nervous system (CNS) neurons, which then induce sleep.
In mammals, CNS neurons that regulate sleep reside in the hypothalamus (Saper et al., 2005b). In C. elegans, the target for EGF action is a single interneuron called ALA (Van Buskirk and Sternberg, 2007), whose developmental program has similarities to the developmental program of mammalian neuroendocrine cells (Van Buskirk and Sternberg, 2010). With EGF activation, ALA depolarizes to release neuropeptides encoded by the gene flp-13 (FMRFamide-Like Peptide-13) to promote sleep (Nelson et al., 2014). FLP-13 peptides are characterized by an amidated Arginine-Phenylalanine (RFamide) motif at their C-termini. RFamide neuropeptides are involved in many physiological functions in both invertebrates (López-Vera et al., 2008; Peymen et al., 2014), and vertebrates (Rőszer and Bánfalvi, 2012; Kim, 2016). In fruit flies, several RFamide neuropeptides regulate sleep (He et al., 2013; Shang et al., 2013), including the RFamide neuropeptide FMRFamide, which regulates SIS (Lenz et al., 2015).
In this study, we focused on understanding the downstream mechanism of the sleep-promoting activity of FLP-13 RFamide peptides. Both locomotion quiescence and feeding quiescence induced by flp-13 can be reversed by activation of motor neurons (Trojanowski et al., 2015), suggesting that flp-13 mediates quiescence at the level of the nervous system. Furthermore, quiescence induced by flp-13 requires the G protein alpha subunit GOA-1 (Trojanowski et al., 2015), suggesting that these peptides signal through a G protein-coupled receptor (GPCR). There are more than 150 genes in the C. elegans genome predicted to encode neuropeptide receptor GPCRs (Frooninckx et al., 2012; Hobert, 2013). In prior detailed analysis of one of these GPCRs (Nelson et al., 2015), we showed that while FRPR-4 can be activated by FLP-13 peptides in cell-based assay, its genetic removal does not abrogate flp-13 induced quiescence in vivo, suggesting that it is not the receptor mediating the quiescence-inducing effects of FLP-13 peptides in response to cellular stress. Since we had no strong a priori reason to implicate other specific GPCRs, we took a hypothesis-independent forward genetic screen approach to identify the FLP-13 receptor (Yuan et al., 2015). We here identify the GPCR DMSR-1 (DroMyoSuppressin Receptor related-1) as required for flp-13 somnogenic effects. DMSR-1 is expressed in about one tenth of all C. elegans neurons and localizes diffusely to membranes. FLP-13 peptides can activate the receptor directly, indicating that DMSR-1 is likely an in vivo receptor for FLP-13 neuropeptides. Inhibition of neurons where dmsr-1 is expressed enhances the effect of flp-13, suggesting that DMSR-1 transduces the FLP-13 signal by reducing activity of wake-promoting neurons.
Our goal was to characterize the downstream mechanism for the sleep-inducing FLP-13 neuropeptides. We induced sleep by over expressing the flp-13 gene in somatic cells under the control of the heat-inducible promoter hsp-16.2 (heat-shock protein-16.2). Phsp-16.2:flp-13 transgenic animals are quiescent for body and pharyngeal movements two hours after exposure to a heat pulse to induce flp-13 gene expression (Nelson et al., 2014). As previously described (Yuan et al., 2015) and illustrated in Figure 1A, we performed a forward mutagenesis screen to identify mutants with defective quiescence in response to flp-13 overexpression. By performing genetic complementation tests, we determined that five of the identified mutants (qn45, qn49, qn51, qn52 and qn53) were alleles of the same gene (Yuan et al., 2015). We found two additional alleles (qn40 and qn44) in this gene by manually screening for mutants with defective feeding quiescence induced by overexpression of flp-13.
To identify the gene mutated to cause the defect in flp-13 induced quiescence, we sequenced the genomes of six of the allelic mutants. Each of the six mutants had a mutation in dmsr-1, a gene predicted to encode a GPCR (Figure 1B). Four of the mutants (qn44, qn49, qn51 and qn53) contained premature stop codons. One mutant (qn45) contained a complex rearrangement in exon 4 consisting of deletion of 332 nucleotides coupled with insertion of 54 nucleotides (Figure 1—figure supplement 1). This rearrangement results in a frame shift that eliminates the three transmembrane domains at the C-terminus of the protein. One mutant (qn52) contained an alanine to valine mutation in exon 3. We Sanger sequenced the dmsr-1 gene in qn40, and found a premature stop mutation in exon 4 (Figure 1B). The six mutations which caused premature stops or a deletion are predicted to eliminate gene function. We do not know whether the missense mutation in qn52 eliminates genes function; however, based on the phenotype and the relatively conservative alanine to valine mutation, the second extracellular loop where this mutation occurred likely plays an important role in the function of DMSR-1. We performed subsequent analyses using the qn45 allele because it was a convincing null mutation and because the genotype could be easily determined using polymerase chain reaction (PCR).
DMSR-1 is one of 41 C. elegans proteins in the RFamide receptor family (Frooninckx et al., 2012) and is orthologous to Drosophila receptors for the neuropeptides dromyosuppressin and FMRFamide. Like FLP-13 peptides, Dromyosuppressin and FMRFamide are neuropeptides with an amidated Arginine-Phenylalanine (RFamide) motif at their C-terminus (Nachman et al., 1993). We grouped the C. elegans DMSR and other RFamide receptor proteins based on their sequence homology to the Drosophila myosuppressin receptors MsR1 and MsR2, which are known to respond to RFamide peptides (Figure 1C). Other RFamide receptors in C. elegans include FRPR (FMRFamide Peptide Receptor family) proteins, and the neuropeptide receptor family (NPR), although these FRPR and NPR receptors are more closely related to the Drosophila FMRFaR than they are to the myosuppressin related receptors. We included in the phylogenetic tree other identified RFamide receptors from the arthropods Anopheles gambiae and Rhodnius prolixus, which also share homology to the Drosophila myosuppressin receptors. Based on its mutant phenotype and its homology to known RFamide receptors, we hypothesized that DMSR-1 is a receptor for FLP-13 neuropeptides.
To measure the degree to which these dmsr-1 mutations suppressed the behavioral quiescence induced by flp-13 overexpression, we subjected Phsp-16.2:flp-13 transgenic animals to a heat pulse. We quantified feeding and locomotion quiescence two hours after induction of flp-13 overexpression – well after the acute effects of heat on quiescence have dissipated (Nelson et al., 2014). All wild-type animals pumped their pharynxes rapidly two hours after the heat pulse whereas the Phsp-16.2:flp-13 transgenic animals showed little to no feeding movements (Figure 2A–B). By contrast, a significant fraction of each of the dmsr-1 mutants had pharyngeal pumping movements despite overexpression of flp-13 (Figure 2A). In the absence of a heat pulse, dmsr-1(qn45) mutants pumped rapidly at a rate no different from wild-type animals (Figure 2B). Following induction of flp-13 overexpression, the rate of pumping in dmsr-1(qn45) mutants was not changed.
To quantify body movements, we recorded worm activity and quiescence using the WorMotel (Churgin and Fang-Yen, 2015). The WorMotel is a polydimethylsulfoxane (PDMS) device consisting of 48 individual wells filled with agar nematode growth medium (NGM) and used to track individual worms over several hours. Two hours after induction of flp-13 overexpression, we recorded body movement activity for two hours by taking images every 10 s. We used image subtraction analysis (Raizen et al., 2008) to determine both the total activity of the animals and the amount of time that each worm spent quiescent following induction of flp-13 overexpression. Following induction of flp-13 overexpression, dmsr-1(qn45) mutants had increased body movement activity and reduced body movement quiescence in comparison to animals that were wild type for dmsr-1 (Figure 2C–D).
We can make a number of predictions based on the hypothesis that DMSR-1 is the receptor for FLP-13 neuropeptides. The first prediction is that, like flp-13 (Nelson et al., 2014), dmsr-1 should be required for quiescence during SIS. The second prediction is that FLP-13 neuropeptides will activate DMSR-1 in a cell-culture system. The third prediction is that dmsr-1 should be expressed in the nervous system. Finally, DMSR-1 should be active in neurons that affect sleep/wake behavior.
In order to test whether dmsr-1 is required for SIS, we first artificially activated the SIS pathway. In response to stress, the C. elegans EGF (called LIN-3) activates the EGF-receptor (called LET-23) on the ALA neuron (Van Buskirk and Sternberg, 2007; Hill et al., 2014). Overexpression of LIN-3/EGF produces a robust sleep state that mimics SIS (Van Buskirk and Sternberg, 2007). While dmsr-1 mutants showed wild-type levels of feeding quiescence in response to EGF overexpression (Figure 3A), they had a small but highly significant defect relative to wild-type worms in body movement quiescence (Figure 3B). This result provides evidence that dmsr-1 is required downstream of or in parallel to EGF. The observation of only partial suppression of the EGF-induced quiescence suggests that there are other ALA-regulated signaling pathways working in parallel to dmsr-1.
To test the hypothesis that dmsr-1 mediates SIS, we induced sleep by exposing the animals to a heat stress of 35°C for 30 min. dmsr-1 mutations suppressed SIS with respect to both body movement quiescence and feeding quiescence (Figure 3C–D). To test whether dmsr-1 was required for SIS after exposure to other temperatures, we exposed cohorts of animals to temperatures ranging from 29 to 37 degrees Celsius. The dmsr-1(qn45) mutation suppressed SIS at temperatures ranging from 34 to 37 degrees (Figure 3—figure supplement 1A). To test whether dmsr-1 was required for sleep in response to stressors other than heat, we exposed animals to ultraviolet C (UVC) radiation. UVC induced a strong body movement quiescent response, which was attenuated in the dmsr-1(qn45) mutant (Figure 3—figure supplement 1B). We partially restored SIS in dmsr-1 mutants by expressing a genomic fragment of dmsr-1 including the coding region and 4 kb of upstream regulatory DNA (Figure 3C,D). It is possible that the incomplete rescue of SIS is due to an absence of dmsr-1 in the full complement of cells where it acts. This incomplete expression may be due to the nature of our extrachromosomal DNA array, which is not inherited by every somatic cell. Alternatively, it is possible that the genomic DNA fragment does not contain all required dmsr-1 regulatory elements. While dmsr-1 mutants were defective in quiescence associated with SIS, they had normal quiescence associated with DTS (Figure 3—figure supplement 1C–D), as previously shown for flp-13 mutants (Nelson et al., 2014), supporting the notion that the DTS and SIS are regulated at least partially differently (Trojanowski et al., 2015).
These experiments therefore demonstrate that, in response to cellular stress, dmsr-1 is required for quiescence of feeding movements and body movements.
To test the prediction that FLP-13 peptides activate DMSR-1 in cell culture, we cloned DMSR-1 isoform A into a mammalian expression vector and transiently expressed the protein in Chinese hamster ovarian (CHO) culture cells. These cells stably express a promiscuous Gα16 subunit as well as an aequorin reporter activated by intracellular calcium fluxes. Gα16 causes a Ca2+ flux in response to receptor activation regardless of the type of G-protein that couples to the receptor in vivo (Figure 4A) (Beets et al., 2011).
We measured the response of cells expressing DMSR-1 isoform A to a range of FLP-13 peptide concentrations. Since the FLP-13 protein is processed into seven distinct RFamide peptides (Figure 4B), we performed a dose-response study with each of these seven peptides. Each of these peptides was capable of activating DMSR-1. The most potent activator was FLP-13–5, which elicited a 50% maximal response (EC50) at a concentration of 2.3 nM (Figure 4B–C). The observed potent activation of DMSR-1 by FLP-13 peptides in this cell based assay supports the hypothesis that DMSR-1 is an in vivo receptor for FLP-13 peptides.
The third prediction made by our model is that dmsr-1 is expressed in the nervous system. This prediction arises from prior studies indicating that the mechanism of feeding and movement quiescence observed with flp-13 overexpression occurs through the inhibition of cholinergic motor neurons (Trojanowski et al., 2015). To test this prediction, we attached the rescuing genomic DNA of dmsr-1 to a trans-splice acceptor site followed by the coding sequence of the red fluorescent protein dsRED (Figure 5A). This Pdmsr-1:dmsr-1:SL2:dsRED transgene rescued the dmsr-1 mutant phenotype (Figure 3C–D), indicating that the construct contains regulatory elements required for appropriate dmsr-1 expression. We observed red fluorescence in several neurons both in the head and tail of the animals (Figure 5B). Based on the location of the cell body, the neuronal process morphology, the co-expression of the transgene with other, well-characterized, green fluorescent protein (GFP) reporters, and the co-localization of the red fluorescence with green DiO fluorescence, we concluded that dmsr-1 is expressed in the RID neuron (Figure 5C), the paired AIY neurons (Figure 5D), 12 other head neurons, the paired PHA and PHB neurons in the tail (Figure 5E), and in five other tail neurons.
Based on additional analysis, we concluded that dmsr-1 is not expressed in several other neurons, which are listed in Supplementary file 1. Importantly, we did not see expression of dmsr-1 in AVE or AVA neurons (Figure 5F). These command interneurons are the only post-synaptic partners to the ALA neuron based on the presence of ultrastructurally-defined chemical synapses (White et al., 1986). The expression in neurons that do not make direct synaptic connections with ALA suggested that ALA signals in a neuroendocrine fashion to promote SIS. In support of this suggestion, we found that a DMSR-1 protein with a GFP fluorescent tag at its C-terminus was localized diffusely to neuronal cell membranes and was not localized to synapses (Figure 5G). This GFP-tagged DMSR-1 protein rescued the mutant phenotype of dmsr-1 (Figure 5—figure supplement 1), indicating that it was functional.
Taken together, these results support a model whereby ALA releases FLP-13 peptides in a neuroendocrine fashion to directly activate DMSR-1 expressed in neurons and thus promote sleep in response to cellular stress. The notion that ALA can signal via non-synaptic means was previously proposed based on the observation that a mutant with disrupted ALA axonal outgrowth retained normal ALA function (Van Buskirk and Sternberg, 2007).
In an attempt to determine which of the neurons observed to express dmsr-1 is sufficient to relay the sleep inducing effect of flp-13 overexpression, we transgenically restored dmsr-1 gene expression in specific neurons in animals otherwise lacking dmsr-1 function. We tested two neuron types—AIY and PHA—where we had the tools to easily express DMSR-1 selectively in a single neuron type. Expression of dmsr-1 in the paired PHA tail sensory neurons was not sufficient to restore feeding or body movement quiescence induced by flp-13 overexpression (Figure 5—figure supplement 2A–C). Expression of dmsr-1 in the paired head AIY interneurons conferred a small but statistically-significant (p<0.01) rescue of the body movement quiescence defect (Figure 5—figure supplement 2D) but not the feeding quiescence defect observed in dmsr-1 mutants during flp-13 overexpression (Figure 5—figure supplement 2A–B). AIY specific dmsr-1 expression did not however rescue the feeding or body movement quiescence defects observed in dmsr-1 mutants during SIS (Figure 5—figure supplement 2E–F).
The fourth prediction from our model is that DMSR-1 signaling affects neurons that control sleep/wake behavior. DMSR-1 may regulate sleep either by activating sleep-promoting neurons or by inhibiting wake-promoting neurons. To distinguish between these possibilities, we inhibited the dmsr-1-expressing cells to test their effects on sleep. If DMSR-1 activation promotes sleep by activating sleep-promoting neurons, then inhibiting these neurons should impair sleep. Conversely, if DMSR-1 activation promotes sleep by inhibiting wake-promoting neurons, then inhibiting these cells would promote sleep.
We inhibited DMSR-1 expressing neurons by using histamine-gated chloride (HisCl) channels. We can use this approach because histamine does not appear to act as a neurotransmitter in C. elegans (Hobert, 2013). In the presence of histamine, HisCl channels allow chloride ions to pass into the neurons to render them less excitable (Liu and Wilson, 2013; Nelson et al., 2014; Pokala et al., 2014). By applying histamine to worms expressing HisCl channels under the control of the dmsr-1 promoter (Pdmsr-1:HisCl), we inhibited dmsr-1 expressing neurons in a spatially- and temporally- controlled fashion. Because non-transgenic animals lack endogenous receptors for histamine (Pokala et al., 2014), they behaved similarly in the presence and absence of histamine (Figure 6). When transgenic worms expressing Pdmsr-1:HisCl worms were placed on histamine, their movement quiescence and total activity were not affected (Figure 6), indicating that in the absence of cellular stress, silencing these neurons has minimal effect on behavior.
We then tested whether activating the HisCl channels affected activity and quiescence after triggering cellular stress. For these experiments, we triggered cellular stress by exposing the animals to ultraviolet (UV) light (Figure 3—figure supplement 1). UV light exposure triggers a robust sleep state that requires ALA and FLP-13 signaling (H. Debardeleben and D. Raizen, unpublished data). The long-lasting effects of UV induced sleep provide a sensitive tool for measuring the effects of neuronal silencing in this experiment. When HisCl worms were placed on histamine following exposure to UV stress, they had reduced total activity and enhanced body movement quiescence compared to control worms that lacked the HisCl channels (Figure 6A–C). Importantly, HisCl channels did not affect activity or quiescence in the absence of histamine.
These observations of elevated body movement quiescence with HisCl activation suggest that DMSR-1 promotes sleep by inhibiting wake-promoting cells.
One neuropeptide (or a group of neuropeptides encoded by the same gene) may activate multiple receptors. Similarly, a given receptor may be activated by multiple neuropeptides. Does the somnogenic effect of FLP-13 neuropeptides result exclusively from the activation of DMSR-1? Do other neuropeptides activate DMSR-1 to induce sleep? We used a double mutant analysis to answer these questions. We compared the SIS phenotypes of flp-13; dmsr-1 double mutant animals to those of dmsr-1 and flp-13 single mutant animals. We reasoned that if flp-13 and dmsr-1 have sleep inducing effects that are independent of one another, then the double mutant will have a greater defect in SIS compared to either of the single mutants. The double mutant animals indeed showed a greater defect in quiescence than either the dmsr-1 or the flp-13 single mutant animals (Figure 7). This result suggests that (1) FLP-13 peptides activate receptors in addition to DMSR-1, and (2) DMSR-1 is either activated by ligands in addition to those encoded by flp-13, or DMSR-1 has ligand-independent activity.
Our findings expand our understanding of how stress induced sleep is regulated in C. elegans (Figure 8). Cellular stress leads to the release of the EGF/LIN-3 (Hill et al., 2014) either from the stressed cells directly or from other cells. EGF activates the ALA neuron through the EGF-receptor LET-23 (Van Buskirk and Sternberg, 2007). This activation requires depolarization of ALA (Nelson et al., 2014). ALA releases neuropeptides encoded by the flp-13 gene (Nelson et al., 2014) as well as other neuropeptides (Nath et al., 2016). FLP-13 neuropeptides then act in a neuroendocrine fashion to activate the G-protein coupled receptor DMSR-1 and thus to inhibit wake-promoting neurons, which include the AIY interneurons. The G-protein that is coupled to DMSR-1 may be the Gi/o alpha subunit GOA-1, since goa-1 mutants are defective in SIS and in flp-13 induced sleep (Trojanowski et al., 2015) and since goa-1 is expressed widely in the nervous system (Ségalat et al., 1995). GOA-1 signaling may ultimately down regulate the activity of the Gq (EGL-30) signaling pathway, since a gain of function mutation in EGL-30 suppresses flp-13 induced sleep (Trojanowski et al., 2015).
The observation that the suppression of quiescence by most of our genetic manipulations is only partial suggests that there are additional complexities in the sleep promoting system downstream of ALA activation. Our double mutant analyses support the notion that FLP-13 peptides act on other receptors in addition to DMSR-1, and that DMSR-1 is activated by peptides other than FLP-13 peptides. The additional receptors responding to FLP-13 peptides may include one or more of the 15 other DMSR proteins encoded in the C. elegans genome (Figure 1C), and the additional peptides acting on DMSR-1 may include one or more of the other neuropeptides released from ALA (Nath et al., 2016).
We showed that selective dmsr-1 expression in the AIY neurons conferred a small but significant rescue of the flp-13 overexpression-induced movement quiescence but did not confer a rescue of SIS. Three possibilities could reconcile these observations. (1) The endogenous FLP-13 peptides that act on the AIY neurons are released from a neuron other than ALA. (2) FLP-13 peptides act on AIY only when expressed at high levels and do not normally do so under physiological conditions. (3) Our SIS assay conditions were not sufficiently sensitive to identify a small rescue in SIS. Regardless of the explanation of these results, since the AIY interneurons are known to promote worm locomotion (Gray et al., 2005; Shtonda and Avery, 2006), our observations that dsmr-1 is expressed in AIY and may function in AIY are consistent with the model that FLP-13/DMSR-1 signaling functions to inhibit wake-promoting neurons.
Although selective dmsr-1 expression in neither AIY nor PHA neurons fully rescued the mutant quiescence phenotype, our findings do not exclude the possibility that dmsr-1 functions selectively in a neuron type that we have not yet tested. Several of the other neurons expressing dmsr-1 remain unidentified and may also promote waking activity. One possibility is the neuroendocrine RID neuron, which promotes forward locomotion (Lim et al., 2016). The alternative to the model that dmsr-1 functions in a small subset of the neurons where it is expressed is that dmsr-1 is simultaneously required in several neurons to promote sleep in response to FLP-13 signaling. In this model, which we favor, restoring dmsr-1 gene expression in only a subset of the neurons in which dmsr-1 is required would not be sufficient to fully rescue the mutant phenotype.
In mammals, wake-promoting centers are distributed broadly across brainstem, basal forebrain, midbrain, and diencephalic structures, but sleep promoting neurons are anatomically restricted (Saper et al., 2005b). The ventrolateral preoptic area of the hypothalamus, which is proposed to be sleep-promoting, contains inhibitory projections to several wake-promoting neurons (Saper et al., 2005a). It is possible that C. elegans similarly has a diffuse wake-promoting circuit that can be inhibited by a central sleep-promoting system, the single ALA neuron. It remains to be seen whether sleep in response to acute illness in other animals functions in a similar fashion, but since RFamide and EGF signaling regulates sleep in arthropods too, it would not be unreasonable to propose that the molecular details and signaling concepts elucidated here are conserved across phylogeny.
Worms were cultivated on the agar surface of NGM medium (1.7% agar), fed the OP50 derivative bacterial strain DA837 (Davis et al., 1995), and maintained at 20 degrees Celsius unless noted otherwise. We found that the type of agar used affected the behavior of animals after heat shock. For experiments reported here we used only granulated agar (Apex, catalog number 20–275).
NQ570: qnIs303[Phsp-16.2:flp-13; Phsp-16.2:GFP; Prab-3:Cherry]
NQ793: dmsr-1(qn40) V; qnIs303
NQ810: dmsr-1(qn44) V; qnIs303
NQ792: dmsr-1(qn45) V; qnIs303
NQ814: dmsr-1(qn49) V; qnIs303
NQ51: dmsr-1(qn51) V; qnIs303
NQ52: dmsr-1(qn52) V; qnIs303
NQ53: dmsr-1(qn53) V; qnIs303
NQ915: dmsr-1(qn45) V
NQ943: flp-13(tm2427) IV; dmsr-1(qn45) V
PS5009: pha-1(e2132ts) III (?); syEx723[Phsp16.2:LIN-3C; Pmyo-2:GFP; pha-1(+)]
NQ978: pha-1(e2132ts) III (?); dmsr-1(qn45) V; syEx723
NQ990: qnEx514[Pdmsr-1:HisCl; Pttx-3:GFP]
NQ1006: qnEx526[Pdmsr-1:mCherry; Punc-122:GFP; pha-1(+); ladder]
NQ1083: unc-119(ed3) III; qnEx585[dmsr-1(fosmid)::GFP; pCFJ151]
NQ1055: dmsr-1(qn45) V; qnEx569[dmsr-1(fosmid)::GFP; Pttx-3:GFP; 1 kb DNA ladder]
NQ1111: dmsr-1(qn45) V; qnEx602[dmsr-1:SL2:dsRed; Pttx-3:GFP; 1 kb DNA ladder]
NQ1142: dmsr-1(qn45); qnEx610[Pttx-3:dmsr-1:SL2:dsRed; Pmyo-2:GFP; 1 kb DNA ladder]
NQ1145: dmsr-1(qn45) V;qnIs303; qnEx610[Pttx-3:dmsr-1:SL2:dsRed; Pmyo-2:GFP; 1 kb DNA ladder];
NQ1147: dmsr-1(qn45) V; qnIs303; qnEx614[Pgcy-17:dmsr-1:SL2:dsRed;Pmyo-2:GFP; 1 kb DNA ladder]
We used the overlap extension PCR method to generate constructs for transgenic analysis (Nelson and Fitch, 2011). Oligonucleotide sequences used for constructs and for sequencing are listed in Supplementary file 2.
Microinjection of extrachromosomal arrays was performed as described in Mello et al. (1991).
Whole genome sequencing was performed at the Wistar Institute Genomics Core Facility and bioinformatics analysis of the sequences was performed at the Wistar Institute Bioinformatics Core Facility.
Crosses with dmsr-1 were performed using either the balancer nT1, which expresses a dominant GFP, or by following the qn45 deletion by PCR analysis using the primers oNQ1480 and oNQ1515.
Except for data shown in Figure 3—figure supplement 1, which was collected from fourth larval stage animals, all behavioral assays were performed in young adult worms. Worms were synchronized by picking larval stage four animals and performing the experiments the following day.
Sleep was induced by exposing the worms to 35°C for 30 min by immersion of their housing Petri dish sealed with Parafilm strips in a circulating water bath and then recovered at room temperature. For experiments in which we assessed feeding behavior by direct observation, we immersed the worms housed on the agar surface of 5.5 cm diameter polystyrene Petri dishes (Azer, Catalog numbers ES3515 and ES3514) containing 10 mL of NGM agar and seeded with DA837 bacteria. For experiments in which we measured body movements using the WorMotel, worms were picked to the WorMotel chip and placed inside an empty plastic 10 cm diameter Petri dish, which was sealed with Parafilm and placed in the heat bath.
The set-up for imaging the WorMotel is described in Churgin and Fang-Yen (2015). The WorMotel is a PDMS device that contains a series of wells filled with NGM agar so that individual worms can be housed separately for longitudinal tracking. The chip was imaged under dark field microscopy using red light to indirectly illuminate worms from below a glass stage as described. Images were taken every ten seconds at a spatial resolution of 16 microns per pixel. Images were analyzed using custom software that subtracts pairs of successive images as previously described (Raizen et al., 2008). Body movement activity was quantified as the total number of pixels changed in the subtracted images, and quiescent epochs were those in which no pixel movement was detected between a pair of frames. The software is available at https://github.com/cfangyen/wormotel.
Sleep was induced by exposing worms to 1500 J/m2 of UVC light (XL-UV Crosslinker, Spectrolinker Incorporated). Worms were picked to the WorMotel chip with a thin coating of bacteria for food and placed in a 10 cm petri dish with the lid removed inside the crosslinker. Behavior was assessed by recording on the WorMotel.
Overexpression of flp-13 or of lin-3 was induced in all somatic cells under the control of the heat shock inducible promoter hsp-16.2. Transcription was activated by immersing plates wrapped with Parafilm in a 33°C water bath for 30 min. To assess body movement quiescence, animals were exposed to heat while on NGM agar dishes, then transferred to the WorMotel chip and imaged. Feeding quiescence was measured two hours following induction of overexpression.
Feeding behavior was assessed by examining pharyngeal pumping under a stereomicroscope using 2-4x objective magnification. Behavior was measured in real time, and the experimenter was blinded to the condition of the worm. A pump was identified as a backwards movement of the grinder, a tooth-like structure in the posterior bulb of the pharynx.
The coding region for the histamine-gated chloride channel was amplified using PCR from the pNP471 plasmid (Pokala et al., 2014), and combined with the dmsr-1 promoter using overlap extension PCR. Worms were raised on NGM media and synchronized at the L4 stage. Young adults expressing Pdmsr-1:HisCl were placed in NGM agar medium with 15 mM histamine immediately prior to UV exposure and imaging on the WorMotel.
Multi-factor analyses were performed using 2-way ANOVA with pairwise post-hoc comparisons using the Bonferroni correction. For post-hoc tests, all comparisons were made against one group. For time course analyses, we used a 2-way ANOVA with the time factor as a repeated measure. One factor analyses were performed using a 1-way ANOVA with pairwise comparisons made using Dunnett’s test. All statistics were performed and graphs were generated using GraphPad Prism 126.96.36.1997 and 6.0 (GraphPad Software, Inc., La Jolla California).
The assessment of FLP-13 peptide activation of DMSR-1 was done as described (Nelson et al., 2015). Briefly, DMSR-1A cDNA was cloned into the pcDNA3.1(+) TOPO expression vector (Thermo Fisher Scientific, Waltham Massachusetts). Receptor activation was studied in Chinese hamster ovary cells (CHO) stably expressing apo-aequorin (mtAEQ) targeted to the mitochondria as well as the human Galpha16 subunit. We used the CHO-K1 cell line (PerkinElmer, ES-000-A2) for receptor activation assays. Quality control and authentication was performed by determining the EC50 for reference agonists (e.g. ATP) in an AequoScreen calcium mobilization assay. A mycoplasma test was performed using the MycoAlert Mycoplasma (Lonza) detection kit. This cell line tested negative for mycoplasma.
The CHO/mtAEQ/Galpha16 cells were cultured in Ham’s F12 medium (Sigma), containing 10% fetal bovine serum (FBS), 100 UI/ml of penicillin/streptomycin, 250 μg/ml Zeocin and 2.5 μg/ ml Fungizone (Amphoterin B). Cell lines were grown at 37°C in a humidified atmosphere of 5% CO2 and were diluted fifteen-fold every third day. CHO/mtAEQ/Galpha16 cells were transiently transfected with the DMSR-1 cDNA construct or the empty pcDNA3.1(+) vector using the Lipofectamine transfection reagent (Thermofisher Scientific), according to the manufacturer’s instructions. Cells expressing the receptor were shifted to 28°C 1 day later, and collected 2 days post-transfection in BSA medium (DMEM/HAM’s F12 with 15 mM HEPES, without phenol red, supplemented with 0.1% BSA) and loaded with 5 μM coelenterazine h (Thermo Fisher) for 4 hr to reconstitute the holo-enzyme aequorin. Cells (25,000 cells/well) were exposed to synthetic peptides in BSA medium, and aequorin bioluminescence was recorded for 30 s on a MicroBeta LumiJet luminometer (PerkinElmer, Waltham Massachusetts) in quadruplicate. For dose-response evaluations, after 30 s of ligand-stimulated calcium measurements, Triton X-100 (0.1%) was added to the well to obtain a measure of the maximum cell Ca2+ response. BSA medium without the peptides was used as a negative control and 1 μM ATP was used to check the functional response of the cells. Cells transfected with the pcDNA3.1 empty vector were used as a negative control for the effect of the receptor. EC50 values were calculated from dose-response curves, constructed using a computerized nonlinear regression analysis, with a sigmoidal dose-response equation (Prism 6.0).
Deorphanizing G protein-coupled receptors by a calcium mobilization assayMethods in Molecular Biology 789:377–391.https://doi.org/10.1007/978-1-61779-310-3_25
A mechanism for sickness sleep: lessons from invertebratesThe Journal of Physiology, 10.1113/JP273009.
Cellular stress induces a protective sleep-like state in C. elegansCurrent Biology 24:2399–2405.https://doi.org/10.1016/j.cub.2014.08.040
What's in a name? roles of RFamide-related peptides beyond gonadotrophin inhibitionJournal of Neuroendocrinology, 28, 10.1111/jne.12407, 27369805.
MEGA7: Molecular evolutionary genetics analysis version 7.0 for bigger datasetsMolecular Biology and Evolution 33:1870–1874.https://doi.org/10.1093/molbev/msw054
FMRFamide signaling promotes stress-induced sleep in DrosophilaBrain, Behavior, and Immunity 47:141–148.https://doi.org/10.1016/j.bbi.2014.12.028
Overlap extension PCR: an efficient method for transgene constructionMethods in Molecular Biology 772:459–470.https://doi.org/10.1007/978-1-61779-228-1_27
Effects of microbial challenge on sleep in rabbitsThe FASEB journal 3:2062–2066.https://doi.org/10.1096/fj.1530-6860
Distinct mechanisms underlie quiescence during two Caenorhabditis elegans sleep-like statesJournal of Neuroscience 35:14571–14584.https://doi.org/10.1523/JNEUROSCI.1369-15.2015
Epidermal growth factor signaling induces behavioral quiescence in Caenorhabditis elegansNature Neuroscience 10:1300–1307.https://doi.org/10.1038/nn1981
The structure of the nervous system of the nematode Caenorhabditis elegansPhilosophical Transactions of the Royal Society B: Biological Sciences 314:1–340.https://doi.org/10.1098/rstb.1986.0056
Eve MarderReviewing Editor; Brandeis University, United States
In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.
Thank you for submitting your article "The RFamide receptor DMSR-1 regulates stress-induced sleep in C. elegans" for consideration by eLife. Your article has been reviewed by two peer reviewers, and the evaluation has been overseen by Eve Marder as the Senior Editor and Reviewing Editor. The following individuals involved in review of your submission have agreed to reveal their identity: Patsy Dickinson (Reviewer #1).
The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.
Please note that both reviewers felt the paper would have substantial impact on the field, but also felt that editorial work would strengthen its impact. In this case, I believe it will be helpful for you to see the initial reviews because they are in essential agreement, and focus on queries that you should answer to make the manuscript more broadly accessible and useful.
This paper provides convincing evidence that the gene dmsr-1 encodes a receptor (DMSR-1) that is activated by FLP-13 peptides, and is important in controlling 'stress-induced sleep', that is, quiescence induced by the effects heat stress or of EGF (presumably acting on the ALA neuron). Using a mutagenesis screen, the authors found that a number of mutants that failed to respond to overexpression of flp-13, and therefore presumably over-stimulation by the FLP-13 peptides had a variety of mutations in the dmsr-1 gene, leading to a failed DMSR-1 receptor. They went on to show that the DMSR-1 receptor binds to the FLP-13 peptides, that it is required for stress-induced sleep, that the dmsr-1 gene is expressed in the nervous system (in a number of specific neurons), and finally that the likely mechanism for the effects of DMSR-1 activation on stress-induced sleep are likely mediated by an inhibition of wake-promoting neurons rather than by an activation of sleep-inducing neurons.
The writing is clear, and it appears to me that the data are appropriately interpreted and make a strong case for their interpretation. Moreover, the manuscript should be of interest to a reasonably wide range of neuroscientists. The ability to manipulate the genetic makeup of C. elegans, together with the existing knowledge of the nervous system, make this a system that works very well for this study.
This manuscript identifies the GPCR DMSR-1 as a novel regulator of stress-induced sleep through an unbiased forward genetic screen for genes that suppress the effects of a sleep-promoting neuropeptide. Complex neural circuits regulate sleep, and investigating sleep regulation in the nematode's relatively simple nervous system has potential to identify defined circuits regulating this process, and how they are modulated by environmental change. These findings build upon previous work identifying the ALA neurons as mediating stress-induced changes in sleep by release of FLP-13 neuropeptide. The identification of DMSR-1 as a target of FLP-13 provides a system for examining neurohormonal modulation of sleep in response to environmental or physiological changes. The experiments are technically sound and will have broad impact on the sleep community. Below I list a number of comments, mostly minor, that I believe would increase the accessibility and impact of this manuscript.
1) Because this journal is geared towards a generalist audience, greater description of the assays and interpretations of results would be helpful.
2) It is not clear why heat was selected as a stressor to characterize SIS in DMSR mutants while UV was used in the HisCL experiments. Using 35 degrees? What about other stressors? It would be very interesting to know if the role of DMSR-1 is generalizable across difference stressors.
3) The impacted would be aided by localizing DMSR-1 function. Speculate on what other. Is it at least possible to separate head and tail populations?
4) In Figure 7, the double mutant effect almost looks additive, which is somewhat surprising. This experiment may benefit from a more detailed analysis e.g. a number of different UV intensities or heat gradients.https://doi.org/10.7554/eLife.19837.017
- Michael J Iannacone
- Christopher Fang-Yen
- David M Raizen
- Michael J Iannacone
- Christopher Fang-Yen
- David M Raizen
- Isabel Beets
- Liliane Schoofs
- Isabel Beets
- Liliane Schoofs
- David M Raizen
- David M Raizen
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
We thank Jessie Zhou, Mark Nessel, and Eve Phelps for technical assistance, Hilary Debardeleben for showing that ultraviolet light causes SIS, and Gregg Artiushin for demonstrating feasibility of flp-13(OE) suppressor screen by isolating the first mutant. We thank Raizen lab members for discussions and comments on this manuscript. A HisCl plasmid was provided by Cori Bargmann. Some strains were provided by the CGC, which is funded by NIH Office of Research Infrastructure Programs (P40-OD010440). This research was supported in part by the National Institutes of Health (R01-NS088432, R21-NS091500, and P30-ES013508), the European Research Council (ERC-2013-ADG-340318), and the Research Foundation Flanders (FWO). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NINDS, NIEHS, NIH, ERC, or the FWO.
- Eve Marder, Reviewing Editor, Brandeis University, United States
- Received: July 20, 2016
- Accepted: December 16, 2016
- Version of Record published: January 17, 2017 (version 1)
© 2017, Iannacone et al.
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.